Fetal RHD typing: Is fetal RHD typing in all RhD negative women cost effective?
- PMID: 18436926
- PMCID: PMC2335264
- DOI: 10.1136/bmj.39556.499549.80
Fetal RHD typing: Is fetal RHD typing in all RhD negative women cost effective?
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study.BMJ. 2008 Apr 12;336(7648):816-8. doi: 10.1136/bmj.39518.463206.25. Epub 2008 Apr 3. BMJ. 2008. PMID: 18390496 Free PMC article.
References
-
- National Institute for Health and Clinical Excellence. Technology appraisal 41. Routine anti-D prophylaxis for pregnant women who are RhD negative. 2002. www.nice.org.uk/page.aspx?o=31679
-
- Chilcott J, Tappenden P, Jones ML, Wight J, Forman K, Wray J, et al. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative. BJOG 2004;111:903-7. - PubMed
-
- Chitty LS, van der Schoot CE, Hahn S, Neil D. Avent SAFE—The Special Non-invasive Advances in Fetal and Neonatal Evaluation Network: aims and achievements. Prenatal Diagn 2008;28:83-8. - PubMed
-
- Geifman-Holtzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood—a meta-analysis. Am J Obstet Gynecol 2006;195:1163-73. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical